EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

MYO6 and Heart: A Novel Variant in a Deaf Infant With Supraventricular Tachycardia

Samira Kalayinia iD, Tannaz Masoumi, Amirreza Taherkhani iD, Nejat Mahdieh iD, Mohammadrafie Khorgami, Majid Maleki

Molecular Genetics & Genomic Medicine · 2026-06 · 14 (6)

DOI: 10.1002/mgg3.70244 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 07.06.2026. Verfasst von Samira Kalayinia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran. Hauptthemen laut MEDLINE: Tachycardia, Supraventricular, Myosin Heavy Chains, Deafness. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Variants in MYO6 are well known causes of hereditary deafness and have occasionally been linked to cardiac abnormalities, including hypertrophic cardiomyopathy and prolonged QT interval. However, supraventricular tachycardia (SVT) has not previously been associated with this gene.

Aim

To describe a neonate with congenital deafness, paroxysmal SVT, and QT prolongation carrying a novel homozygous MYO6 variant.

Methods

A 2‐month‐old male infant with bilateral congenital sensorineural hearing loss presented with recurrent paroxysmal SVT. Clinical evaluation included ECG, Holter monitoring, echocardiography, and laboratory studies. Whole‐exome sequencing followed by Sanger validation was performed to identify genetic alterations.

Results

The infant experienced repeated SVT episodes responsive to adenosine and was noted to have a prolonged QTc interval of 569 ms in sinus rhythm. Echocardiography showed mild LV enlargement with preserved function and no structural anomalies. Genetic testing revealed a novel homozygous frameshift variant in MYO6 (c.2496_2497delAC; p.H833Qfs*5).

Conclusion

While causality cannot be confirmed, this observation raises the possibility that MYO6 dysfunction may contribute to arrhythmogenic susceptibility in addition to its established role in auditory function. Further studies are warranted to clarify the relationship between MYO6 variants and cardiac conduction abnormalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, SupraventricularMyosin Heavy ChainsDeafnessHumansMaleInfantFrameshift MutationHomozygote

Stichwörter der Autor:innen

congenitaldeafnessheart diseaseparoxysmal supraventricular tachycardiaprolonged QT interval

Substanzen

Myosin Heavy Chains

Autor:innen und Institutionen

  • Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
  • Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
  • Cardiovascular Research Center, Shahid Behehsti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Samira Kalayinia, Amirreza Taherkhani, Nejat Mahdieh

Zitieren

APA

Kalayinia, S., Masoumi, T., Taherkhani, A., Mahdieh, N., Khorgami, M., & Maleki, M. (2026). MYO6 and Heart: A Novel Variant in a Deaf Infant With Supraventricular Tachycardia. Molecular Genetics & Genomic Medicine, 14(6). https://doi.org/10.1002/mgg3.70244

Vancouver

Kalayinia S, Masoumi T, Taherkhani A, Mahdieh N, Khorgami M, Maleki M. MYO6 and Heart: A Novel Variant in a Deaf Infant With Supraventricular Tachycardia. Molecular Genetics & Genomic Medicine. 2026;14(6). doi:10.1002/mgg3.70244

BibTeX
@article{Kalayinia2026,
  author = {Kalayinia, Samira and Masoumi, Tannaz and Taherkhani, Amirreza and Mahdieh, Nejat and Khorgami, Mohammadrafie and Maleki, Majid},
  title = {MYO6 and Heart: A Novel Variant in a Deaf Infant With Supraventricular Tachycardia},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1002/mgg3.70244}
}
Kostenlos starten →